Cargando…

Pulmonary Metastasectomy in Pediatric Solid Tumors

Metastatic disease and the complications of treating metastatic disease are the primary causes of mortality in children with solid malignancies. Nearly 25% of children with solid tumors have metastatic disease at initial diagnosis and another 20% develop metastases during or after treatment. The mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Croteau, Nicole J., Heaton, Todd E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352020/
https://www.ncbi.nlm.nih.gov/pubmed/30626161
http://dx.doi.org/10.3390/children6010006
_version_ 1783390722321285120
author Croteau, Nicole J.
Heaton, Todd E.
author_facet Croteau, Nicole J.
Heaton, Todd E.
author_sort Croteau, Nicole J.
collection PubMed
description Metastatic disease and the complications of treating metastatic disease are the primary causes of mortality in children with solid malignancies. Nearly 25% of children with solid tumors have metastatic disease at initial diagnosis and another 20% develop metastases during or after treatment. The most common location of these metastases is the lung. The role of surgery in metastatic disease depends greatly on the histology of the primary. In general, tumors that are refractory to adjuvant therapies are most appropriate for pulmonary metastasectomy. This article will summarize the indications for metastasectomy in pediatric solid tumors and discuss the ongoing debate over the technique of metastasectomy in osteosarcoma.
format Online
Article
Text
id pubmed-6352020
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63520202019-02-01 Pulmonary Metastasectomy in Pediatric Solid Tumors Croteau, Nicole J. Heaton, Todd E. Children (Basel) Review Metastatic disease and the complications of treating metastatic disease are the primary causes of mortality in children with solid malignancies. Nearly 25% of children with solid tumors have metastatic disease at initial diagnosis and another 20% develop metastases during or after treatment. The most common location of these metastases is the lung. The role of surgery in metastatic disease depends greatly on the histology of the primary. In general, tumors that are refractory to adjuvant therapies are most appropriate for pulmonary metastasectomy. This article will summarize the indications for metastasectomy in pediatric solid tumors and discuss the ongoing debate over the technique of metastasectomy in osteosarcoma. MDPI 2019-01-08 /pmc/articles/PMC6352020/ /pubmed/30626161 http://dx.doi.org/10.3390/children6010006 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Croteau, Nicole J.
Heaton, Todd E.
Pulmonary Metastasectomy in Pediatric Solid Tumors
title Pulmonary Metastasectomy in Pediatric Solid Tumors
title_full Pulmonary Metastasectomy in Pediatric Solid Tumors
title_fullStr Pulmonary Metastasectomy in Pediatric Solid Tumors
title_full_unstemmed Pulmonary Metastasectomy in Pediatric Solid Tumors
title_short Pulmonary Metastasectomy in Pediatric Solid Tumors
title_sort pulmonary metastasectomy in pediatric solid tumors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352020/
https://www.ncbi.nlm.nih.gov/pubmed/30626161
http://dx.doi.org/10.3390/children6010006
work_keys_str_mv AT croteaunicolej pulmonarymetastasectomyinpediatricsolidtumors
AT heatontodde pulmonarymetastasectomyinpediatricsolidtumors